Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,080
Closed -$999K 478
2026
Q1
$999K Sell
2,080
-211
-9% -$108K 0.07% 236
2025
Q4
$1.29M Buy
+2,291
New +$1.3M 0.16% 173
2025
Q3
Sell
-5,141
Closed -$1.61M 607
2025
Q2
$1.61M Buy
5,141
+300
+6% +$90.1K 0.18% 146
2025
Q1
$1.48M Buy
+4,841
New +$1.63M 0.15% 188
2024
Q4
Sell
-6,594
Closed -$2.2M 514
2024
Q3
$2.2M Buy
6,594
+4,103
+165% +$1.56M 0.26% 112
2024
Q2
$1.03M Sell
2,491
-3,008
-55% -$1.19M 0.13% 213
2024
Q1
$2.22M Buy
+5,499
New +$1.93M 0.18% 148
2023
Q1
Sell
-4,382
Closed -$931K 628
2022
Q4
$931K Buy
+4,382
New +$875K 0.15% 175
2021
Q3
Sell
-360
Closed -$64K 661
2021
Q2
$64K Buy
360
+49
+16% +$8.46K 0.01% 677
2021
Q1
$51K Buy
+311
New +$47.6K 0.02% 542
2020
Q4
Sell
-1,013
Closed -$113K 1049
2020
Q3
$113K Buy
1,013
+643
+174% +$74.3K 0.07% 278
2020
Q2
$34K Buy
+370
New +$31.5K 0.01% 724

Other funds holding MEDP

FORA Capital's MEDP Position: Q2 2026 in Review

FORA Capital sold out of Medpace (MEDP) in Q2 2026, closing a stake of 2,080 shares — an estimated $999K sold.

FORA Capital first reported a position in MEDP in Q2 2020 and held it in 12 quarters. The position peaked at $2.22M in Q1 2024. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • FORA Capital reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • FORA Capital sold 2,080 Medpace shares in Q2 2026, an estimated $999K.
  • FORA Capital first reported a position in Medpace in Q2 2020 and held it in 12 quarters.
  • FORA Capital's Medpace position peaked at $2.22M in Q1 2024.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on FORA Capital's 13F filing for Q2 2026, filed 13 Aug 2026.